Page last updated: 2024-10-30

lomustine and Vomiting

lomustine has been researched along with Vomiting in 16 studies

Vomiting: The forcible expulsion of the contents of the STOMACH through the MOUTH.

Research Excerpts

ExcerptRelevanceReference
"Thirty-seven consecutive patients with disseminated malignant melanoma and previously untreated with chemotherapy were randomly allocated to receive vindesine, cis-platinum, and etoposide (Regimen A) or vindesine, cis-platinum, and lomustine (Regimen B)."9.05Prospective randomized trial in advanced malignant melanoma with cis-platinum, vindesine, and etoposide vs. cis-platinum, vindesine, and lomustine. ( Bajetta, E; Bonadonna, G; Buzzoni, R; Nava, M; Vaglini, M; Viviani, S, 1985)
"One hundred and six patients with advanced adenocarcinoma and large cell carcinoma of the lung with no prior chemotherapy were entered in a prospectively randomized trial comparing cyclophosphamide, doxorubicin, and cisplatin versus methotrexate, doxorubicin, cyclophosphamide, and lomustine."5.05Comparison of combination chemotherapy programs in advanced adenocarcinoma-large cell carcinoma of the lung: a North Central Cancer Treatment Group study. ( Cullinan, S; Eagan, RT; Elliott, T; Etzell, P; Fleming, TR; Krook, JE; Pfeifle, D, 1984)
"Thirty-seven consecutive patients with disseminated malignant melanoma and previously untreated with chemotherapy were randomly allocated to receive vindesine, cis-platinum, and etoposide (Regimen A) or vindesine, cis-platinum, and lomustine (Regimen B)."5.05Prospective randomized trial in advanced malignant melanoma with cis-platinum, vindesine, and etoposide vs. cis-platinum, vindesine, and lomustine. ( Bajetta, E; Bonadonna, G; Buzzoni, R; Nava, M; Vaglini, M; Viviani, S, 1985)
"Forty-three patients with inoperable or recurring malignant gliomas, and 30 patients with multiple recurring brain metastases were treated with a combination of Adriamycin (45 mg/m2) and 4-dimethyl-epipodophyllotoxin D-thenylidene (VM 26) (60 mg/m2 for 2 days) with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) (60 mg/m2 for 2 days)."3.65Treatment of malignant gliomas and brain metastases in adults with a combination of adriamycin, VM 26, and CCNU. Results of a phase II trail. ( Gauthier, H; Huguenin, P; Lheritier, J; Mathe, G; Morin, P; Parrot, R; Poisson, M; Pouillart, P; Thy, TH, 1976)
"Lomustine is a commercially available chloroethyl nitrosourea compound whose antitumor activity in vitro and in animal tumor models exceeds its activity in humans."2.67A phase I trial of weekly lomustine in patients with advanced cancer. ( Benjamin, RS; Gorski, CC; Koller, CA; Legha, SS; Papadopoulos, NE; Plager, C, 1994)
" The dosage of CCNU was 100 mg/m2 p."2.65The superiority of CCNU in the treatment of advanced Hodgkin's disease: Cancer and Leukemia Group B Study. ( Brunner, K; Cuttner, J; Falkson, G; Hansen, HH; Holland, JF; Nissen, NI; Pajak, TF; Selawry, OS; Spurr, CL, 1981)
"It is an effective drug in the treatment of malignant melanoma with better response rates in women than in men."2.64Phase I evaluation of DTIC (NSC-45388) and other studies in malignant melanoma in the Central Oncology Group. ( Hill, G; Johnson, RO; Krementz, E; Metter, G; Wilson, W, 1976)
"The severity of emesis is dependent on the dose of cyclophosphamide and on the addition of other cytotoxic drugs."2.39Optimal control of cyclophosphamide-induced emesis. ( Stewart, A, 1996)

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-199013 (81.25)18.7374
1990's2 (12.50)18.2507
2000's0 (0.00)29.6817
2010's1 (6.25)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pavlů, J1
Auner, HW1
Ellis, S1
Szydlo, RM1
Giles, C1
Contento, A1
Rahemtulla, A1
Apperley, JF1
Naresh, K1
MacDonald, DH1
Kanfer, EJ1
Seigler, HF1
Lucas, VS1
Pickett, NJ1
Huang, AT1
Diggs, CH1
Wiernik, PH1
Sutherland, JC1
Cianfriglia, F1
Pompili, A1
Riccio, A1
Grassi, A1
Krook, JE1
Fleming, TR1
Eagan, RT1
Cullinan, S1
Pfeifle, D1
Elliott, T1
Etzell, P1
Chahinian, AP1
Green, G1
Holland, JF2
Hansen, HH1
Selawry, OS1
Pajak, TF1
Spurr, CL1
Falkson, G1
Brunner, K1
Cuttner, J1
Nissen, NI1
Koller, CA1
Gorski, CC1
Benjamin, RS1
Legha, SS1
Papadopoulos, NE1
Plager, C1
Stewart, A1
Reagan, TJ1
Bisel, HF1
Childs, DS1
Layton, DD1
Rhoton, AL1
Taylor, WF1
Alberto, P1
Barrelet, L1
Chapuis, B1
Garcia, B1
Johnson, RO1
Metter, G1
Wilson, W1
Hill, G1
Krementz, E1
Pouillart, P1
Mathe, G1
Thy, TH1
Lheritier, J1
Poisson, M1
Huguenin, P1
Gauthier, H1
Morin, P1
Parrot, R1
Tummarello, D1
Guidi, F1
Porfiri, E1
Isidori, P1
Raspugli, M1
Cellerino, R1
Page, JP1
Levi, JA1
Woods, RL1
Tattersall, MN1
Fox, RM1
Coates, AS1
Bajetta, E1
Buzzoni, R1
Viviani, S1
Vaglini, M1
Nava, M1
Bonadonna, G1

Reviews

1 review available for lomustine and Vomiting

ArticleYear
Optimal control of cyclophosphamide-induced emesis.
    Oncology, 1996, Volume: 53 Suppl 1

    Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epirubic

1996

Trials

11 trials available for lomustine and Vomiting

ArticleYear
Treatment of advanced untreated Hodgkin's disease with SCAB--an alternative to MOPP.
    Cancer, 1981, Jan-15, Volume: 47, Issue:2

    Topics: Adult; Bleomycin; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Hodg

1981
CCNU-chemotherapy of hemispheric supratentorial glioblastoma multiforme.
    Cancer, 1980, Mar-15, Volume: 45, Issue:6

    Topics: Adolescent; Adult; Aged; Bone Marrow; Brain Neoplasms; Clinical Trials as Topic; Female; Glioblastom

1980
Comparison of combination chemotherapy programs in advanced adenocarcinoma-large cell carcinoma of the lung: a North Central Cancer Treatment Group study.
    Cancer treatment reports, 1984, Volume: 68, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell;

1984
Mitomycin-C, etoposide, cisplatin, and hexamethylmelamine (MEPH) as a second-line regimen in lung cancer.
    American journal of clinical oncology, 1984, Volume: 7, Issue:5

    Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cy

1984
The superiority of CCNU in the treatment of advanced Hodgkin's disease: Cancer and Leukemia Group B Study.
    Cancer, 1981, Jan-01, Volume: 47, Issue:1

    Topics: Adult; Carmustine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration S

1981
A phase I trial of weekly lomustine in patients with advanced cancer.
    Cancer, 1994, Jan-01, Volume: 73, Issue:1

    Topics: Administration, Oral; Adult; Aged; Capsules; Carcinoma, Renal Cell; Drug Administration Schedule; Dr

1994
Controlled study of CCNU and radiation therapy in malignant astrocytoma.
    Journal of neurosurgery, 1976, Volume: 44, Issue:2

    Topics: Adult; Aged; Brain Neoplasms; Digestive System; Drug Evaluation; Glioblastoma; Hematopoiesis; Humans

1976
A combination of adriamycin, CCNU and hydroxyurea in the treatment of disseminated bronchogenic carcinoma.
    European journal of cancer, 1975, Volume: 11, Issue:11

    Topics: Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Clinical Trials as Topic; Doxorubicin; Drug Thera

1975
Phase I evaluation of DTIC (NSC-45388) and other studies in malignant melanoma in the Central Oncology Group.
    Cancer treatment reports, 1976, Volume: 60, Issue:2

    Topics: Carmustine; Clinical Trials as Topic; Dacarbazine; Drug Evaluation; Drug Therapy, Combination; Femal

1976
Randomized trial of combination chemotherapy in hormone-resistant metastatic prostate carcinoma.
    Cancer treatment reports, 1985, Volume: 69, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Do

1985
Prospective randomized trial in advanced malignant melanoma with cis-platinum, vindesine, and etoposide vs. cis-platinum, vindesine, and lomustine.
    American journal of clinical oncology, 1985, Volume: 8, Issue:5

    Topics: Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic

1985

Other Studies

4 other studies available for lomustine and Vomiting

ArticleYear
LACE-conditioned autologous stem cell transplantation for relapsed or refractory diffuse large B-cell lymphoma: treatment outcome and risk factor analysis from a single centre.
    Hematological oncology, 2011, Volume: 29, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy;

2011
DTIC, CCNU, bleomycin and vincristine (BOLD) in metastatic melanoma.
    Cancer, 1980, Dec-01, Volume: 46, Issue:11

    Topics: Antineoplastic Agents; Bleomycin; Carmustine; Drug Administration Schedule; Drug Evaluation; Drug Th

1980
Treatment of malignant gliomas and brain metastases in adults with a combination of adriamycin, VM 26, and CCNU. Results of a phase II trail.
    Cancer, 1976, Volume: 38, Issue:5

    Topics: Adult; Aged; Brain Neoplasms; Doxorubicin; Drug Therapy, Combination; Drug Tolerance; Female; Glioma

1976
Results of a combined chemo-radiotherapeutic program in 61 patients affected by small cell lung cancer.
    Tumori, 1988, Apr-30, Volume: 74, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Small Cell; Cis

1988